| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $59.10M | $83.89M | $103.70M | $161.25M | $125.70M |
| R&D | $26.88M | $46.18M | $54.81M | $113.32M | $90.62M |
| SG&A | $32.22M | $37.72M | $48.89M | $47.93M | $35.08M |
| Operating Income | -$59.10M | -$83.89M | -$103.70M | -$161.25M | -$125.70M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$57.39M | -$79.98M | -$98.79M | -$157.04M | -$125.75M |
| EPS (basic) | -1.4500 | -2.6500 | -3.2800 | -5.3000 | -7.1600 |
| EPS (diluted) | -1.4500 | -2.6500 | -3.2800 | -5.3000 | -7.1600 |
| Shares (diluted) | $39.48M | $30.16M | $30.10M | $29.63M | $17.55M |